AU2017900935A0 - Heterocyclic inhibitors of PCSK9 - Google Patents

Heterocyclic inhibitors of PCSK9

Info

Publication number
AU2017900935A0
AU2017900935A0 AU2017900935A AU2017900935A AU2017900935A0 AU 2017900935 A0 AU2017900935 A0 AU 2017900935A0 AU 2017900935 A AU2017900935 A AU 2017900935A AU 2017900935 A AU2017900935 A AU 2017900935A AU 2017900935 A0 AU2017900935 A0 AU 2017900935A0
Authority
AU
Australia
Prior art keywords
pcsk9
heterocyclic inhibitors
heterocyclic
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900935A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardio Therapeutics Pty Ltd
Original Assignee
Cardio Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Cardio Therapeutics Pty Ltd filed Critical Cardio Therapeutics Pty Ltd
Publication of AU2017900935A0 publication Critical patent/AU2017900935A0/en
Assigned to Cardio Therapeutics Pty Ltd reassignment Cardio Therapeutics Pty Ltd Amend patent request/document other than specification (104) Assignors: Altnia Operations Pty Ltd
Priority to PCT/AU2018/050243 priority Critical patent/WO2018165718A1/en
Priority to US16/494,899 priority patent/US11091466B2/en
Priority to EP18768188.7A priority patent/EP3609882B1/en
Priority to US17/363,721 priority patent/US11897868B2/en
Abandoned legal-status Critical Current

Links

AU2017900935A 2017-03-17 2017-03-17 Heterocyclic inhibitors of PCSK9 Abandoned AU2017900935A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/AU2018/050243 WO2018165718A1 (en) 2017-03-17 2018-03-16 Heterocyclic inhibitors of pcsk9
US16/494,899 US11091466B2 (en) 2017-03-17 2018-03-16 Heterocyclic inhibitors of PCSK9
EP18768188.7A EP3609882B1 (en) 2017-03-17 2018-03-16 Heterocyclic inhibitors of pcsk9
US17/363,721 US11897868B2 (en) 2017-03-17 2021-06-30 Heterocyclic inhibitors of PCSK9

Publications (1)

Publication Number Publication Date
AU2017900935A0 true AU2017900935A0 (en) 2017-03-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP3541932A4 (en) Inhibitors of crispr-cas9
EP3600318A4 (en) Methods of using ehmt2 inhibitors
EP3463343A4 (en) Heterocyclic inhibitors of ptpn11
EP3684361A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3700527A4 (en) Papd5 inhibitors and methods of use thereof
EP3697420A4 (en) Methods of using ehmt2 inhibitors in immunotherapies
EP3429591A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3589284A4 (en) Uses of pyrimidopyrimidinones as sik inhibitors
EP3551625A4 (en) Heterocyclic inhibitors of mct4
EP3801503A4 (en) Inhibitors of sarm1
EP3510040A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3102576B8 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
EP3131900A4 (en) Heterocyclic kinase inhibitors
EP3609882A4 (en) Heterocyclic inhibitors of pcsk9
EP3906029A4 (en) Inhibitors of menin-mll interaction
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3856176A4 (en) Inhibitors of vap-1
EP3638229A4 (en) Imidazole-containing inhibitors of alk2 kinase
EP3668839A4 (en) Heterocyclic inhibitors of atr kinase
EP3651768A4 (en) Heterocyclic inhibitors of atr kinase
EP3386505A4 (en) Aza-benzimidazole inhibitors of pad4
EP3142652A4 (en) Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
EP3710430A4 (en) Acss2 inhibitors and methods of use thereof
EP3728260A4 (en) Exo-aza spiro inhibitors of menin-mll interaction
EP3458448A4 (en) Methods of using fasn inhibitors